The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Fri., Jan. 24, 7:19 AM

Slide #8. Protalix BioTherapeutics, Inc. (AMEX:PLX) 1 for 10 Reverse Split

Announced: 12/9/2019
Stock Split: 1 for 10
Record Date: 12/18/2019
Pay Date: 12/19/2019
PLX Optionable?: Yes

Protalix BioTherapeutics is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx® protein expression system. Co. has developed taliglucerase alfa for the treatment of Gaucher disease. Co.'s product pipeline includes, among other candidates, pegunigalsidase alfa, or PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; alidornase alfa, or PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 under development for the treatment of Cystic Fibrosis, to be administered by inhalation; and OPRX-106, Co.'s oral anti Tumor, Necrosis Factor product candidate.
PLX Detailed Information Page & Split History »

Company Name: 
Protalix BioTherapeutics Inc
Website: 
www.protalix.com
Sector: 
Biotechnology

Open the PLX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
84th percentile
(ranked higher than approx. 84% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.